NutraceuticalF

Fo-Ti

Fo-Ti (Polygonum multiflorum / He Shou Wu)

Traditional medicine ingredient with no quality RCTs — and documented hepatotoxicity case reports.

FEvidence grade
1Claims evaluated
0Key human trials
0 / 5Strength for hair
Mechanism & evidence strength

How Fo-Ti works — and how well we know it

Mechanism of action

Traditional medicine use for premature graying and hair loss. Modern mechanism is poorly characterized; some in vitro suggestion of follicle stimulation.

Unspecified
Route

oral, topical

Typical dose

Variable; included in proprietary blends at undisclosed doses.

Regulatory status

Traditional Chinese medicine ingredient. No regulatory approval for AGA. Documented hepatotoxicity case reports.

Best for

Nothing we'd recommend.

Evidence distribution across 1 claims

In Silico
In Vitro
In Vivo
Ex Vivo
Open-Label1
RCT

Why the grade is F. No quality RCT evidence for AGA. Documented liver toxicity case reports make the risk-benefit calculus poor.

Evidence breakdown

Every claim, traced back to its source

We took every major claim made about Fo-Ti and matched it to the specific experimental model behind it. Click a claim to see the model, the finding, and our assessment of how much weight it deserves.

1 claims · evidence-by-evidence breakdown

1
Open-LabelWeight: High
Fo-Ti has documented hepatotoxicity case reports
Real liver-toxicity risk. With no AGA benefit established, the calculus is negative.
The experimental model

Multiple case reports and case series of severe hepatitis temporally associated with chronic fo-ti supplementation, including liver-transplant cases.

The finding

Chronic fo-ti use has caused severe hepatitis in multiple documented cases.

Our assessment

The risk is real and documented. With no offsetting AGA efficacy evidence, the risk-benefit is clearly negative.

Citations
Open questions

What's still missing from the science

  • Any quality AGA-specific evidence.
Bottom line

Our verdict on Fo-Ti

Real liver risk, no hair benefit
Fo-Ti's hair-loss claims rest on traditional Chinese medicine usage, with no quality RCT evidence in modern medical literature. Meanwhile, the safety side of the ledger contains documented case reports of severe hepatitis — including cases requiring liver transplant. The risk-benefit calculus is straightforwardly negative. We don't recommend it.
Documented liver toxicity risk with no AGA benefit established. Avoid.
At Anagen

Not in our formulary yet

We don't carry this ingredient. We only formulate around actives where the evidence — and the safety profile — is strong enough to recommend with confidence. As the data matures, we may revisit.

Fo-Ti: Evidence-Based Hair Loss Review | Anagen